Stem cell transplant offers lifesaving hope for rare immune disorder

NCT ID NCT01176006

First seen Sep 30, 2025 · Last updated May 27, 2026 · Updated 28 times

Summary

This study tests whether a stem cell transplant from a matched sibling, unrelated donor, or half-matched parent can fix the immune system in people with DOCK8 deficiency, a genetic condition that causes severe infections and cancer. Participants receive chemotherapy and sometimes radiation before the transplant, then drugs to prevent the donor cells from attacking their body. The goal is to reduce life-threatening infections and improve long-term health.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DOCK8 DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

Conditions

Explore the condition pages connected to this study.